Canadian cannabis sales lifted in November

Canadian cannabis sales lifted in November, signaling a notable shift in the post legalization market. Sales rose 6.6 percent to C$477.9 million, according to Statistics Canada, and that increase matters for investors and operators alike. Because the rise came after several soft months, it may mark a turning point for retail momentum.

On a per day basis, growth reached 10.2 percent because November had fewer days than October. However, provincial results diverged. Ontario and Alberta eased month to month, while British Columbia rebounded sharply and Quebec showed strong year over year gains.

This article will examine the data and key drivers behind the lift. Additionally, we will unpack the role of more retail stores, falling flower prices, and illicit market displacement. Finally, we offer practical takeaways for retailers, investors, and policymakers as December data approaches.

Canadian cannabis sales lifted in November: Key drivers and market dynamics

Canadian cannabis sales lifted in November because several forces converged. Statistics Canada reported a 6.6 percent rise to C$477.9 million. However, the headline masks varied provincial performance and technical distortions.

Key drivers behind the November cannabis sales trends and broader cannabis market growth include:

• Per-day accounting effect: November had fewer days, which raised per-day growth to about 10.2 percent.
• More retail stores opened, improving legal access and convenience across provinces. Therefore, foot traffic and market reach expanded.
• Falling flower prices made legal cannabis more price competitive with illicit sellers. As a result, consumers shifted to licensed channels.
• Product mix shifted toward extracts and edibles, boosting average basket values and legal cannabis sales revenue.
• Provincial swings influenced totals. British Columbia rebounded sharply, while Ontario and Alberta softened month to month.
• Promotions and restocking after weak months supported a sequential rebound in retail activity.
• Regulatory adjustments and licensing approvals eased supply constraints in some markets, therefore improving shelf availability.
• Revisions to October figures changed sequential comparisons, so analysts must consider adjusted baselines.

Market watchers such as New Cannabis Ventures track these trends closely. For the official release see Statistics Canada and for analysis see New Cannabis Ventures.

Canadian cannabis sales lifted in November: Evidence and analysis

Statistics Canada reported that Canadian cannabis sales lifted in November by 6.6 percent to C$477.9 million. Moreover, sales rose 4.6 percent year over year. However, analysts should note that October figures were revised downward to C$448.5 million from C$451.7 million, which affects sequential comparisons. For the official release see Statistics Canada.

Provincial performance varied, and that adds nuance to the headline. Ontario sales fell 5.2 percent month to month and were down 3 percent year over year. Alberta slid 5.5 percent from October but remained up about 2 percent from last year. British Columbia rebounded strongly, rising roughly 250 percent sequentially and 9 percent year over year. Quebec declined 4.1 percent from October yet surged 31 percent versus the prior year.

Part of the November lift came from calendar mechanics. Because November had fewer days, per-day growth measured about 10.2 percent. Additionally, broader drivers supported the trend. More retail stores opened, so legal access increased. Falling flower prices made licensed product more competitive, therefore pulling some buyers from the illicit market. Product mix shifts toward extracts and edibles also raised average basket values.

Market reports and industry commentary back this interpretation. For example, New Cannabis Ventures tracks retail patterns and investor signals closely. See New Cannabis Ventures analysis. In the words of the release, “The December sales data will be released on February 20th,” which provides an important next checkpoint for the market.

Finally, longer term context matters. Total 2024 sales rose 4.5 percent to C$5.39 billion, and sales have climbed another 4.2 percent so far in 2025. Therefore, while November shows momentum, analysts should monitor December data and provincial trends before calling a sustained recovery.

CONCLUSION

Canadian cannabis sales lifted in November, rising 6.6 percent to C$477.9 million. Because this gain followed several soft months, it suggests renewed retail momentum and healthier legal cannabis sales. However, the headline masks meaningful provincial variation and calendar effects.

More stores and lower flower prices helped licensed sellers win back customers from illicit channels. In addition, product mix shifts toward extracts and edibles raised basket values. At the same time, October revisions and the per-day accounting effect explain some of the sequential lift, so analysts should interpret the data carefully.

Therefore, the near-term outlook is cautiously positive. Market fundamentals point to gradual cannabis market growth, yet provincial swings and holiday season effects remain risks. The December release on February 20 will clarify whether November marks a sustained rebound.

Stay informed with reliable research. MyCBDAdvisor is a U.S. blog offering research-driven CBD knowledge and resources on cannabinoids, hemp, and industry trends. For up-to-date coverage visit MyCBDAdvisor and follow their analysis for trusted transparency and practical insights.

Frequently Asked Questions (FAQs)